Tumor-specific CD8+ T cells, CD4+ T cells, and B cells have all been described in extracranial tumors,4, 5, 6, 7, 8 but the prevalence, phenotype, and antigen specificity of these cells in BrMs is unclear. This evidence concerns the gene CD8A and neoplasm.